Open Innovation practices on firm performance: evidences from biotech industry

Risultato della ricerca: Paper

Abstract

The research presented in this paper explores the effect of Open Innovation (OI) on firm performance in the biotech-pharma industry sector. Specifically, although existing researches on OI effectiveness have separately investigated the effect of OI practices on innovation and financial performance, this study evaluates the concurrent effect of all those practices on both such performance dimensions in a single framework. We claim the importance for a manager to explore concurrently the influence of specific OI practices both on innovation and economic-financial performance. We empirically test our framework on a sample of 120 companies listed on NASDAQ Biotechnology Index.
Lingua originaleEnglish
Stato di pubblicazionePublished - 2012

Fingerprint

Open innovation
Industry
Firm performance
Biotech
Financial performance
Listed companies
Managers
Innovation performance
Biotechnology
Innovation
Economics

Cita questo

@conference{c93335096e7c4108ab40a1e62e3f47b3,
title = "Open Innovation practices on firm performance: evidences from biotech industry",
abstract = "The research presented in this paper explores the effect of Open Innovation (OI) on firm performance in the biotech-pharma industry sector. Specifically, although existing researches on OI effectiveness have separately investigated the effect of OI practices on innovation and financial performance, this study evaluates the concurrent effect of all those practices on both such performance dimensions in a single framework. We claim the importance for a manager to explore concurrently the influence of specific OI practices both on innovation and economic-financial performance. We empirically test our framework on a sample of 120 companies listed on NASDAQ Biotechnology Index.",
keywords = "Open Innovation; Firm Performance; Biotech-pharma industry",
author = "Giovanni Perrone and Manfredi Bruccoleri and Erica Mazzola",
year = "2012",
language = "English",

}

TY - CONF

T1 - Open Innovation practices on firm performance: evidences from biotech industry

AU - Perrone, Giovanni

AU - Bruccoleri, Manfredi

AU - Mazzola, Erica

PY - 2012

Y1 - 2012

N2 - The research presented in this paper explores the effect of Open Innovation (OI) on firm performance in the biotech-pharma industry sector. Specifically, although existing researches on OI effectiveness have separately investigated the effect of OI practices on innovation and financial performance, this study evaluates the concurrent effect of all those practices on both such performance dimensions in a single framework. We claim the importance for a manager to explore concurrently the influence of specific OI practices both on innovation and economic-financial performance. We empirically test our framework on a sample of 120 companies listed on NASDAQ Biotechnology Index.

AB - The research presented in this paper explores the effect of Open Innovation (OI) on firm performance in the biotech-pharma industry sector. Specifically, although existing researches on OI effectiveness have separately investigated the effect of OI practices on innovation and financial performance, this study evaluates the concurrent effect of all those practices on both such performance dimensions in a single framework. We claim the importance for a manager to explore concurrently the influence of specific OI practices both on innovation and economic-financial performance. We empirically test our framework on a sample of 120 companies listed on NASDAQ Biotechnology Index.

KW - Open Innovation; Firm Performance; Biotech-pharma industry

UR - http://hdl.handle.net/10447/76650

M3 - Paper

ER -